Evidence map›Paper›PMID 25113557›Full record

ArticleBMJ open2014

Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia.

Werner C Albrich, Shabir A Madhi, Peter V Adrian, Nadia van Niekerk, Jean-Noel Telles, N Ebrahim, Melina Messaoudi, Glaucia Paranhos-Baccalà, Sven Giersdorf, Guy Vernet and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Journal of clinical microbiology · 2018
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Werner C AlbrichDivision of Infectious Diseases and Hospital Epidemiology, Kantonsspital St Gallen, St Gallen, Switzerland Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases University of the Witwatersrand, Johannesburg, South Africa.
Peter V AdrianMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Nadia van NiekerkMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Jean-Noel TellesEmerging Pathogens Laboratory, Fondation Mérieux, Lyon, France.
N EbrahimMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Melina MessaoudiEmerging Pathogens Laboratory, Fondation Mérieux, Lyon, France.
Glaucia Paranhos-BaccalàEmerging Pathogens Laboratory, Fondation Mérieux, Lyon, France.
Sven GiersdorfThermo Scientific Biomarkers, Hennigsdorf, Germany.
Guy VernetEmerging Pathogens Laboratory, Fondation Mérieux, Lyon, France Centre Pasteur du Cameroun, Yaoundé, Cameroun.
Beat MuellerDepartment of Internal Medicine, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland.
Keith P KlugmanMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa Hubert Department of Global Health and Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA Pneumonia Program, Bill and Melinda Gates Foundation, Seattle, Washington, USA.
Fondation Mérieux · FRChris Hani Baragwanath Hospital · ZAKantonsspital Aarau · CHNational Research Foundation · ZARespiratory and Meningeal Pathogens Research Unit · ZAUniversity of the Witwatersrand · ZA

Funding

PHS HHS P30 A1050409
6 · The paper itself

Abstract

objectiveA high genomic load of Pneumococcus from blood or cerebrospinal fluid has been associated with increased mortality. We aimed to analyse whether nasopharyngeal colonisation density in HIV-infected patients with community-acquired pneumonia (CAP) is associated with markers of disease severity or poor outcome.

methodsQuantitative lytA real-time PCR was performed on nasopharyngeal swabs in HIV-infected South African adults hospitalised for acute CAP at Chris Hani Baragwanath Hospital, Soweto, South Africa. Pneumonia aetiology was considered pneumococcal if any sputum culture or Gram stain, urinary pneumococcal C-polysaccharide-based antigen, blood culture or whole blood lytA real-time PCR revealed pneumococci.

resultsThere was a moderate correlation between the mean nasopharyngeal colonisation densities and increasing CURB65 scores among all-cause patients with pneumonia (Spearman correlation coefficient r=0.15, p=0.06) or with the Pitt bacteraemia score among patients with pneumococcal bacteraemia (p=0.63). In patients with pneumococcal pneumonia, nasopharyngeal pneumococcal colonisation density was higher among non-survivors than survivors (7.7 vs 6.1 log10 copies/mL, respectively, p=0.02) and among those who had pneumococci identified from blood cultures and/or by whole blood lytA real-time PCR than those with non-bacteraemic pneumococcal pneumonia (6.6 vs 5.6 log10 copies/mL, p=0.03). Nasopharyngeal colonisation density correlated positively with the biomarkers procalcitonin (Spearman correlation coefficient r=0.37, p<0.0001), proadrenomedullin (r=0.39, p=0.008) and copeptin (r=0.30, p=0.01).

conclusionsIn addition to its previously reported role as a diagnostic tool for pneumococcal pneumonia, quantitative nasopharyngeal colonisation density also correlates with mortality and prognostic biomarkers. It may also be useful as a severity marker for pneumococcal pneumonia in HIV-infected adults.

Indexed as

Severity of Illness IndexAdolescentAdrenomedullinAdultBacteremiaBiomarkersCalcitoninCalcitonin Gene-Related PeptideCommunity-Acquired InfectionsHIV InfectionsHospitalizationHumansNasopharynxPneumoniaPneumonia, PneumococcalProtein PrecursorsAdrenomedullinBiomarkersCALCA protein, humanCalcitoninCalcitonin Gene-Related PeptideproadrenomedullinProtein Precursors

Identifiers

PMID25113557
PMCPMC4127937
OpenAlexW2140153828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.